Cefdinir

Product NDC: 0781-6078
11-digit product format: 007816078
Labeler code: 0781
Product ID: 0781-6078_990055e8-68da-4714-8a9b-02fbb244b570
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Sandoz Inc
Application: ANDA065337
Marketing category: ANDA
Marketing start: 2007-04-06
Marketing end: 0000-00-00
Substance: CEFDINIR
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0781-6078		D	Discontinued by firm	2026-08-17
excluded package	package	0781-6078	0781-6078-46	D	Discontinued by firm	2026-08-17
excluded package	package	0781-6078	0781-6078-61	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-6078-61	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0781-6078-46	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-6078-61	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0781-6078-46	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-6078-61	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0781-6078-46	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-6078-61	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0781-6078-46	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-6078-61	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0781-6078-46	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-6078-61	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0781-6078-46	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-6078-61	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0781-6078-46	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-6078-61	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0781-6078-46	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-6078-61	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0781-6078-46	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-6078-61	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0781-6078-46	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-6078-61	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0781-6078-46	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-6078-61	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0781-6078-46	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A065337-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06
A065337-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A065337-001	AB
A065337-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	RS	2007-04-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	RS	2007-04-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	RS	2007-04-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	RS	2007-04-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065337-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2007-04-06	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065337-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	RS	2007-04-06	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A065337-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A065337-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A065337-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A065337-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065337-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A065337-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A065337-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A065337-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065337-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A065337-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065337-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A065337-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065337-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A065337-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065337-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A065337-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065337-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A065337-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065337-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A065337-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A065337-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A065337-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065337-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A065337-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065337-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A065337-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065337-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A065337-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A065337-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A065337-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065337-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A065337-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A065337-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A065337-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A065337-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A065337-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A065337-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A065337-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A065337-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A065337-002	AB	1	`bb7c543d1eb4…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0781-6078-46	ML - Milliliter	0781-6078	fc2abb94-e540-4a5a-93d1-dfdc1088dd8f	1	2012-07-24
0781-6078-61	ML - Milliliter	0781-6078	532a9038-a9de-404d-b589-dcef9e55f2d0	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEFDINIR	ACTIVE INGREDIENT	CI0FAO63WC	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
CEFDINIR	ACTIVE MOIETY	CI0FAO63WC	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
ANHYDROUS TRISODIUM CITRATE	INACTIVE INGREDIENT	RS7A450LGA	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
GUAR GUM	INACTIVE INGREDIENT	E89I1637KE	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
STRAWBERRY	INACTIVE INGREDIENT	4J2TY8Y81V	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
SUCROSE	INACTIVE INGREDIENT	C151H8M554	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	CEFDINIR POWDER, FOR SUSPENSION [SANDOZ INC]	12

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CI0FAO63WC	CEFDINIR	91832-40-5	CEFDINIR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0781-6078-46	00781607846	100 mL in 1 BOTTLE (0781-6078-46)	100 ml	2007-04-06	0000-00-00	No	No	Current
0781-6078-61	00781607861	60 mL in 1 BOTTLE (0781-6078-61)	60 ml	2007-04-06	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir for Oral Suspension	Sandoz Inc	2020-06-29	HUMAN PRESCRIPTION DRUG LABEL	15
Cefdinir for Oral Suspension	Proficient Rx LP	2019-10-01	HUMAN PRESCRIPTION DRUG LABEL	2
Cefdinir for Oral Suspension	Preferred Pharmaceuticals Inc.	2019-07-12	HUMAN PRESCRIPTION DRUG LABEL	2